FDA Okays Ofev to Treat Idiopathic Pulmonary Fibrosis

October 16, 2014 10:35 AM

6 0

FDA Okays Ofev to Treat Idiopathic Pulmonary Fibrosis

The U.S. FDA Panel gave a green signal to Ofev, a kinase inhibitor, to treat idiopathic pulmonary fibrosis.

In a latest announcement, the U.S. Food and Drug Administration revealed that it has approved Ofev (nintedanib) to treat idiopathic pulmonary fibrosis (IPF), a condition in which the lungs get progressively scarred over time.

Read more

To category page

Loading...